Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases
David D. Kim, Alasdair M. Barr, Cynthia Lu, et al.
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 3, pp. 151-160
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 4, pp. 200-214
Open Access | Times Cited: 132
A Focused Review of the Metabolic Side-Effects of Clozapine
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
Dara Gammon, Catherine Cheng, Anna Volkovinskaia, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 51
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 17
Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
Hélène Verdoux, Clélia Quilès, José de León
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 347-358
Closed Access | Times Cited: 4
Obsessive-compulsive symptoms and personal recovery in patients with schizophrenia spectrum disorders: A cross-sectional study
Auke Jelsma, Frederike Schirmbeck, Marieke van der Pluijm, et al.
Schizophrenia Research (2025) Vol. 276, pp. 24-30
Open Access
Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review
Evelyn Moreno Tarazona, M. González, Aurélie Giron, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Clozapine-Related Obsessive Compulsive Symptoms in an Adolescent with Bipolar Disorder
İrem Cihanyurdu Erdem, Ayşe Burcu Erdoğdu Yıldırım, Neşe Perdahlı Fiş
Psychiatry Research Case Reports (2025), pp. 100258-100258
Open Access
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: Clinical and cognitive determinants of dysfunctional checking
Marjan Biria, Paula Banca, Isaac Jarratt Barnham, et al.
Psychological Medicine (2025) Vol. 55
Closed Access
Overcoming clozapine’s adverse events: a narrative review of systematic reviews and meta-analyses
Timothy Tanzer, Betty Pham, Nicola Warren, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 811-831
Closed Access | Times Cited: 3
Disclosing common biological signatures and predicting new therapeutic targets in schizophrenia and obsessive–compulsive disorder by integrated bioinformatics analysis
Abdolhakim Ghanbarzehi, Ali Sepehrinezhad, Nazanin Hashemi, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD)
Simone Pardossi, Alessandro Cuomo, Andrea Fagiolini
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4739-4739
Open Access | Times Cited: 2
Efficacy and tolerability of aripiprazole versus D2 antagonists in the early course of schizophrenia: a systematic review and meta-analysis
David D. Kim, Alasdair M. Barr, Lulu Lian, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 17
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
Licia Vellucci, Mariateresa Ciccarelli, Elisabetta Filomena Buonaguro, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1220-1220
Open Access | Times Cited: 5
Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendations
Hélène Verdoux, Clélia Quilès, José de León
Schizophrenia Research (2023) Vol. 268, pp. 243-251
Closed Access | Times Cited: 5
Review of Management Considerations for Excoriation Disorder in Older Adults
Michael Mandarino, Lauren Stummer, Ana F. Trueba, et al.
American Journal of Geriatric Psychiatry (2024)
Closed Access | Times Cited: 1
Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms
Gamze Gürcan, Şevin Hun Şenol, A. Elif Anıl Yağcıoğlu, et al.
Psychiatry Research (2021) Vol. 296, pp. 113665-113665
Closed Access | Times Cited: 10
Suicidal Ideation and Obsessive-Compulsive Disorder: Links and Knowledge
Lindsay Benster, Cory R. Weissman, Zafiris J. Daskalakis
Psychology Research and Behavior Management (2022) Vol. Volume 15, pp. 3793-3807
Open Access | Times Cited: 7
Obsessive-compulsive symptoms in the schizophrenia-spectrum: current developments in psychopathology research
Andreas Rosén Rasmussen, Andrea Raballo
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 3, pp. 166-171
Closed Access | Times Cited: 3
Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
Tommaso Accinni, Marianna Frascarelli, F. Ghezzi, et al.
Clinical Case Reports (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 5
A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms
Şule Bıçakcı Ay, Kader Karlı Oğuz, Elçin Özçelik Eroğlu, et al.
Human Psychopharmacology Clinical and Experimental (2022) Vol. 38, Iss. 1
Closed Access | Times Cited: 3
Relationship between clozapine dose and severity of obsessive-compulsive symptoms
David D. Kim, Alasdair M. Barr, S. Evelyn Stewart, et al.
Medical Hypotheses (2021) Vol. 148, pp. 110506-110506
Closed Access | Times Cited: 4
Clozapine
Yvonne W.-H. Yang, Stephen R. Marder
American Psychiatric Association Publishing eBooks (2024)
Closed Access
Treatment of Obsessive-Compulsive Disorder
Reilly Kayser, H. Blair Simpson
American Psychiatric Association Publishing eBooks (2024)
Closed Access
Mutismo persistente e transtorno obsessivo-compulsivo secundário à clozapina em paciente com esquizofrenia e catatonia: um relato de caso
Matheus Alheiros Cassundé, João Cortez de Oliveira, Leticia Araujo Sampaio Mendes, et al.
Debates em Psiquiatria (2024) Vol. 14, pp. 1-10
Open Access
Page 1 - Next Page

Scroll to top